Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Upper urinary tract urothelial cancers: where it is A:T

Nature Reviews Cancer volume 12, pages 503–504 (2012)Cite this article

Subjects

Abstract

Despite a ban on the use of plants of the Aristolochia genus in herbal medicine, as they contain known carcinogens, urothelial carcinoma attributable to the use of this plant seems to be more common than previously thought.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mengs, U. Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol. 61, 504–505 (1988).

    Article  CAS  Google Scholar 

  2. Nortier, J. L. et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342, 1686–1692 (2000).

    Article  CAS  Google Scholar 

  3. Chen, C. H. et al. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl Acad. Sci. USA 109, 8241–8246 (2012).

    Article  CAS  Google Scholar 

  4. Grollman, A. P. et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl Acad. Sci. USA 104, 12129–12134 (2007).

    Article  CAS  Google Scholar 

  5. Nedelko, T. et al. TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours. Int. J. Cancer 124, 987–990 (2009).

    Article  CAS  Google Scholar 

  6. Arlt, V. M. et al. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 28, 2253–2261 (2007).

    Article  CAS  Google Scholar 

  7. Yang, M. H. et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59, 681–687 (2002).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon, 69372, France

    Magali Olivier, Kurt Straif & Christopher P. Wild

  2. University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK

    Monica Hollstein

  3. DKFZ, Im Nevenheimer Feld 280, Heidelberg, 69120, Germany

    Monica Hollstein & Heinz Hans Schmeiser

Authors
  1. Magali Olivier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Hollstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heinz Hans Schmeiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kurt Straif
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christopher P. Wild
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher P. Wild.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

DATABASES

IARC TP53

FURTHER INFORMATION

IARC homepage

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olivier, M., Hollstein, M., Schmeiser, H. et al. Upper urinary tract urothelial cancers: where it is A:T. Nat Rev Cancer 12, 503–504 (2012). https://doi.org/10.1038/nrc3311

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrc3311

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer